Umeclidinium and Vilanterol Ellipta
NDC 66993-134, umeclidinium bromide and vilanterol trifenatate, powder, from Prasco Laboratories.
- Product NDC
- 66993-134
- Status
- Listed
- Labeler
- Prasco Laboratories
- Dosage form
- POWDER
- Route
- RESPIRATORY (INHALATION)
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA203975
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/66993-134 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- UMECLIDINIUM BROMIDE62.5 ug/1
- VILANTEROL TRIFENATATE25 ug/1
Pharmacologic classes
Adrenergic beta2-Agonists [MoA]; Anticholinergic [EPC]; Cholinergic Antagonists [MoA]; beta2-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 66993-134-97 | 66993013497 | 1 TRAY in 1 CARTON (66993-134-97) / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6de414b1-f707-4b98-9e4b-742032ec90afNADAC price for package 66993013497
GET /v1/drugs/nadac/66993013497
Use it
Look up 66993-134 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/66993-134 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 66993-134. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.